XM does not provide services to residents of the United States of America.
B
B

BPERBanca

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

S&P revises Iccrea outlook to 'positive', affirms '/A-3' on 7 Italian banks

BRIEF-S&P revises Iccrea outlook to 'positive', affirms 'BBB-/A-3' on 7 Italian banks June 18 (Reuters) - S&P Global in a statement: S&P GLOBAL: REVISES ICCREA BANCA OUTLOOK TO 'POSITIVE' FROM 'STABLE, AFFIRMS 'BBB-/A-3' RATINGS S&P GLOBAL: AFFIRMS 'BBB-/A-3' RATINGS ON BANCO BPM AND BPER BANCA WITH POSITIVE OUTLOOK S&P GLOBAL: AFFIRMS 'BBB-/A-3' R
B
B

Fitch Ratings Expects Major Italian Banks' Impaired Loans Ratios To Stay Below 4% In 2024, 2025

BRIEF-Fitch Ratings Expects Major Italian Banks' Impaired Loans Ratios To Stay Below 4% In 2024, 2025 June 18 (Reuters) - Fitch Ratings: MAJOR ITALIAN BANKS' IMPAIRED LOANS RATIOS TO STAY BELOW 4% IN 2024, 2025 (Gdansk Newsroom)
U
B
B
I

Italy - Factors to watch on June 18

Italy - Factors to watch on June 18 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . COMPANIES UNICREDIT CRDI.MI The bank said on Monday it was "well above " MREL requirements set by the Single Resolution Board (SRB) and the Bank of Italy, with MREL eligible liabilities equal to 32.8% of risk-weighe
A
E
I
I
L
L
M
R
U
A
B
B
F
I
U

Italy's bad loan manager doValue to buy rival Gardant, shares surge

UPDATE 3-Italy's bad loan manager doValue to buy rival Gardant, shares surge Add CEO quote in paragraphs 5-6, new shareholding in paragraph 13, detail By Claudia Cristoferi, Gnaneshwar Rajan and Alberto Chiumento June 6 (Reuters) - Italy's doValue DOVA.MI has agreed to buy rival Gardant in a cash-and-stock deal, the country's biggest bad loan company said early on Friday, bulking up in the face of ebbing flow of impaired debt due to banks' surprisingly healthy loan books.
B

Italy's doValue rallies after it agrees to buy Gardant

BUZZ-Italy's doValue rallies after it agrees to buy Gardant ** Shares in Italy's doValue DOVA.MI jump as much as 9.9% after the bad loan manager has agreed to buy rival Gardant in a cash and stock deal ** The deal has "strategic sense", Equita says, as doValue will gain access to Gardant's ongoing contract with Banca BPM and BPER Banca, improving i
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.